8-K 1 eightk.txt EIGHTK.TXT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 5, 2003 AMERICAN BIO MEDICA CORPORATION -------------------------------- (Exact Name of Registrant as Specified in its Charter)
New York 0-28666 14-1702188 ------------------------------- ------------------------ ------------------------------------ (State or Other Jurisdiction of (Commission File Number) (IRS Employer Identification Number) Incorporation)
122 Smith Road, Kinderhook, NY 12106 --------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (800) 227-1243 ITEM 5. OTHER MATTERS On February 5, 2003, Daniel W. Kollin was appointed to the Registrant's Board of Directors. Mr. Kollin is a principal of BioMed Capital Group Ltd, a firm that offers strategic and business advisory services, based in Fairfield, New Jersey. Mr. Kollin was also appointed to the Registrant's Nominating Committee. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits. The following exhibits are filed with this report on Form 8-K: 99.1 American Bio Medica Corporation press release dated February 12, 2003. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMERICAN BIO MEDICA CORPORATION (Registrant) Dated: February 12, 2003 By: /s/ Keith E. Palmer ------------------------------ Keith E. Palmer Chief Financial Officer Exhibit Index Exhibit No. Description Page No. ----------- ----------- -------- 99.1 American Bio Medica Corporation press 5 release dated February 12, 2003.